v3.26.3
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Dec. 31, 2025
Cash flows from operating activities:          
Net increase (decrease) in net assets resulting from operations $ 4,787 $ 2,548 $ 10,311 $ 5,782  
Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash provided by (used in) operating activities:          
Net realized (gain) loss 0 0 (87) 0  
Net change in unrealized (appreciation) depreciation 66 (225) 2,469 (586)  
Purchases of investments     (290,851) (226,452)  
Payment-in-kind interest income capitalized     (381) 0  
Proceeds from sales and principal repayments     125,535 20,628  
Net amortization (accretion) on investments     (1,087) (376)  
Amortization of deferred financing costs     764 469  
Changes in operating assets and liabilities:          
Interest receivable from non-controlled/non-affiliated investments     (2,327) (1,139)  
Dividend receivable from controlled/affiliated investments     (251) (425)  
Due from affiliate     (378) 23  
Receivable for investments sold     (270) (31)  
Other assets     0 (5)  
Interest payable     1,020 1,393  
Income incentive fees payable     330 369  
Professional fees payable     757 153  
Due to affiliate     (956) 0  
Management fees payable     82 96  
Administration fees payable     20 24  
Accrued expenses and other liabilities     (66) 366  
Payables for investment purchased     (3,032) 0  
Capital gains incentive fees payable     (85) 63  
Distribution and shareholder servicing fees payable     70 82  
Net cash provided by (used in) operating activities     (158,413) (199,566)  
Cash flows from financing activities:          
Borrowings of debt     323,350 413,939  
Repayments of debt     (250,382) (299,639)  
Subscriptions received in advance     4,180 0  
Proceeds from shares sold     88,513 94,803  
Income distributions to common shareholders, net of distributions payable and reinvested     (11,313) (4,823)  
Deferred financing costs paid     (183) (4,453)  
Net cash provided by (used in) financing activities     154,165 199,827  
Net increase (decrease) in cash, cash equivalents and foreign currencies     (4,248) 261  
Cash, cash equivalents and foreign currencies at beginning of period     19,247 3,855 $ 3,855
Cash, cash equivalents, and foreign currencies at end of period $ 14,999 $ 4,116 14,999 4,116 $ 19,247
Supplemental cash flow information          
Interest paid during the period     8,601 3,707  
Reinvestment of distributions during the period     1,123 0  
Payment-in-kind interest income     $ 381 $ 0